<doc>
  <docmeta id="113hr5587ih">
    <bill congress="113" type="hr" number="5587" version="ih"/>
    <revision size="7988" annotations="0" status="complete" id="4" commit-time="2014-10-09T23:30:21Z" committer="mbohmer" doc="113hr5587ih/4.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H93B2674D497249C8BFB2E8AEABD7E4C6" public-private="public">
	<metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 HR 5587 IH: Opioid Abuse Prevention and Treatment Act of 2014</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. House of Representatives</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2014-09-18</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>2d Session</session>
		<legis-num>H. R. 5587</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20140918">September 18, 2014</action-date>
			<action-desc>
        <sponsor name-id="F000454">Mr. Foster</sponsor> (for himself, <cosponsor name-id="M001185">Mr. Sean Patrick Maloney of New York</cosponsor>, <cosponsor name-id="R000577">Mr. Ryan of Ohio</cosponsor>, <cosponsor name-id="E000290">Ms. Edwards</cosponsor>, <cosponsor name-id="E000293">Ms. Esty</cosponsor>, and <cosponsor name-id="S001170">Ms. Shea-Porter</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To reduce opioid misuse and abuse.</official-title>
	</form>
	<legis-body id="H79FAFB483EAF41A5BAE68F566C37EFE3" style="OLC">
		<section id="H484B2C2872D34C4486D85B9920E984C8" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the <quote>
          <short-title>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Opioid Abuse Prevention and Treatment Act of 2014" proposed="true">Opioid Abuse Prevention and Treatment Act of 2014</cato:entity-ref>
          </short-title>
        </quote>.</text>
		</section>
    <section commented="no" id="H707DBE42B74B496991FAE173DADE3495">
      <enum>2.</enum>
      <header>Pilot project</header>
			<subsection commented="no" id="HF8FCCB66EFDC4F2FBAC1DB89A45C4178">
        <enum>(a)</enum>
        <header>In general</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary of Health and Human Services</cato:entity-ref> (referred to in this Act as the <quote>Secretary</quote>) shall award grants to one or more States to carry out a 1-year pilot project to develop a
			 standardized peer review process and methodology to review and evaluate
			 prescribing and pharmacy dispensing patterns, through a review of
			 prescription drug monitoring programs (referred to in this section as <quote>PDMP</quote>) in the States receiving such grants.</text>
			</subsection>
      <subsection commented="no" id="H8E72FD213B6240428146DF817829B594">
        <enum>(b)</enum>
        <header>Methodology</header>
        <text display-inline="yes-display-inline">The recipients of a grant under this section shall develop a systematic, standardized methodology
			 to identify and investigate questionable or inappropriate prescribing and
			 dispensing patterns of substances on schedule II or III under <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:202">section 202
			 of the Controlled Substances Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/812">
            <cato:entity-ref entity-type="uscode" value="usc/21/812">21 U.S.C. 812</cato:entity-ref>
          </external-xref>)</cato:entity>. Such peer review
			 methodology and prescribing and dispensing patterns shall be shared with
			 the appropriate State regulators and health profession boards.</text>
			</subsection>
      <subsection commented="no" id="HB09B3ED7F88A420BA8081821AA074E4D">
        <enum>(c)</enum>
        <header>Requirements</header>
        <text>A State receiving a grant under this section—</text>
				<paragraph commented="no" id="HF1717F5018A24A9C98ACF182173EBE21">
          <enum>(1)</enum>
          <text>with respect to controlled substances for which a prescriber is required to be registered with by
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1524" entity-type="federal-body">Drug Enforcement Administration</cato:entity-ref> in order to prescribe such controlled
			 substances, shall make the information with respect to such controlled
			 substances from the PDMP available to State regulators and licensing
			 boards; and</text>
				</paragraph>
        <paragraph commented="no" id="H755379DF9FB14E1CB55A44B1EC1695DD">
          <enum>(2)</enum>
          <text>with respect to any other controlled substances, may make the information with respect to such
			 controlled substances from the PDMP available to State regulators and
			 licensing boards.</text>
				</paragraph>
      </subsection>
      <subsection commented="no" id="H85F44E5939394351B52B85105AA46E64">
        <enum>(d)</enum>
        <header>Subgrantees</header>
        <text>A quality improvement organization with which the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> has entered into a contract under <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Social Security Act/t:XI/pt:B">part
			 B of title XI of the Social Security Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/1320c">
            <cato:entity-ref entity-type="uscode" value="usc/42/1320c/etseq">42 U.S.C. 1320c et seq.</cato:entity-ref>
          </external-xref>)</cato:entity> may
			 serve as the subgrantee under this subsection to develop peer review
			 processes as described in subsection (a).</text>
			</subsection>
    </section>
    <section commented="no" id="HFEE4CDBC03114B2882ADD4B91858474D">
      <enum>3.</enum>
      <header>Prescription drug, heroin, and other controlled substance abuse prevention</header>
      <text display-inline="no-display-inline">
        <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Public Health Service Act/t:III/pt:P">Part P of title III of the Public Health Service Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/280g">
          <cato:entity-ref entity-type="uscode" value="usc/42/280g">42 U.S.C. 280g</cato:entity-ref>
        </external-xref>)</cato:entity> is amended by adding at the
			 end the following:</text>
			<quoted-block display-inline="no-display-inline" id="HE356481021254CFA97F110DEBF22EB7E" style="OLC">
				<section id="H991DBD5EA5634286897EC9FE43C8221D">
          <enum>399V–6.</enum>
          <header>Prescription drug, heroin, and other controlled substance abuse prevention</header>
					<subsection commented="no" id="HAFEED553D4C843248D724DDF87A04F40">
            <enum>(a)</enum>
            <header>Training grants</header>
						<paragraph commented="no" id="H48B86BA7724741F99F3736CEC083297C">
              <enum>(1)</enum>
              <header>In general</header>
              <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall award 5-year grants to eligible entities to facilitate training in order to
			 increase the capacity of health care providers to conduct patient
			 screening, brief interventions, and referral to treatment as needed, such
			 as in health care settings to prevent the abuse of prescription drugs,
			 heroin, and other controlled substances. The grant program under this
			 section may be coordinated with the Screening Brief Intervention and
			 Referral to Treatment grant program of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7522" entity-type="federal-body">Substance Abuse and Mental
			 Health Services Administration</cato:entity-ref>, or other appropriate programs.</text>
						</paragraph>
            <paragraph commented="no" id="HE9243783993B419CBC7EC747FA736F4B">
              <enum>(2)</enum>
              <header>Eligible entities</header>
              <text>In this subsection, the term <term>eligible entity</term> includes—</text>
							<subparagraph commented="no" id="HF0C092D0EF584186A216C5FB29E39497">
                <enum>(A)</enum>
                <text>States;</text>
							</subparagraph>
              <subparagraph id="H48FB455F44E741E0AFBA718A6EF0130B">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">physician organizations;</text>
							</subparagraph>
              <subparagraph commented="no" id="HA78457CBD10340A281D368FE8CA62CB1">
                <enum>(C)</enum>
                <text>continuing education entities, such as health profession boards or health accrediting bodies;</text>
							</subparagraph>
              <subparagraph id="H89130B1DC36448648812AAD6FD61B162">
                <enum>(D)</enum>
                <text>peer recovery organizations; and</text>
							</subparagraph>
              <subparagraph commented="no" id="H728EAB331DF545B8B0759C991A8EF382">
                <enum>(E)</enum>
                <text>other appropriate health or professional education organizations or institutions.</text>
							</subparagraph>
            </paragraph>
          </subsection>
          <subsection commented="no" id="H1B7A04A06B94448DAAE65F0DA45FADFF">
            <enum>(b)</enum>
            <header>Expansion of prescribing authority</header>
            <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, acting through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7526" entity-type="federal-body">Administrator of the Health Resources and Services
			 Administration</cato:entity-ref>, shall award grants to States for the purpose of evaluating
			 the prospect of the health professions board of such States reviewing and
			 expanding prescribing authorities of providers, such as advance practice
			 nurses and physician's assistants, with respect to prescribing drugs for
			 the treatment of the abuse of prescription drugs, heroin, or other
			 controlled substances.</text>
          </subsection>
        </section>
        <after-quoted-block>.</after-quoted-block>
      </quoted-block>
		</section>
    <section id="H19170A069BF84D18B8FD86BA287EA26C">
      <enum>4.</enum>
      <header>Prescription drug abuse training and screening programs</header>
			<subsection commented="no" id="HB6E762B3098046B4961E872632C39EFC">
        <enum>(a)</enum>
        <header>Continuing education grants</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall award grants to States to develop continuing education criteria and review
			 processes that allow State health profession boards or State agencies to
			 certify appropriate education and training for informed and safe
			 prescribing of opioids and other drugs listed on schedule II or III under
			 <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:202">section 202 of the Controlled Substances Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/812">
            <cato:entity-ref entity-type="uscode" value="usc/21/812">21 U.S.C. 812</cato:entity-ref>
          </external-xref>)</cato:entity>.</text>
			</subsection>
      <subsection commented="no" id="H3EC26589D31E49FE89F60595357590F9">
        <enum>(b)</enum>
        <header>Screening program</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1500" entity-type="federal-body">Attorney General</cato:entity-ref> shall request that a practitioner registered under <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:303/ss:f">section 303(f) of the
			 Controlled Substances Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/823">
            <cato:entity-ref entity-type="uscode" value="usc/21/823/f">21 U.S.C. 823(f)</cato:entity-ref>
          </external-xref>)</cato:entity> conduct patient screening for
			 potential drug misuse or abuse before prescribing a drug listed on
			 schedule II or III under <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:202">section 202 of the Controlled Substances Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/21/812">21
			 U.S.C. 812</cato:entity-ref>)</cato:entity>, according to standards established by the applicable State
			 licensing body.</text>
			</subsection>
    </section>
    <section id="H8D358A7ECFDF43E5A8317FC80738291F">
      <enum>5.</enum>
      <header>FDA review of naloxone</header>
      <text display-inline="no-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, acting through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7524" entity-type="federal-body">Commissioner of Food and Drugs</cato:entity-ref>, shall conduct a review of
			 naloxone to consider whether naloxone should cease to be subject to
			 <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:b">section 503(b) of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/21/353/b">21 U.S.C.
			 353(b)</cato:entity-ref>)</cato:entity> and be available as an over-the-counter drug, in order to increase
			 access to such drug.</text>
		</section>
    <section id="H222A5D740F974CA99E0170BB173B8AE7">
      <enum>6.</enum>
      <header>Prescription drug disposal</header>
      <text display-inline="no-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall convene or coordinate with an existing entity an interagency working group—</text>
			<paragraph id="H6F5D0232853E4BA9B98BFC7DE03C3124">
        <enum>(1)</enum>
        <text>to encourage States and local governments to increase opportunities for disposal of opiates, such
			 as frequent <quote>take-back programs</quote> and fixed medicine disposal sites at law enforcement public buildings; and</text>
			</paragraph>
      <paragraph id="H8C974F72450943AE931ED51F89F804CD">
        <enum>(2)</enum>
        <text>to reduce opportunities for abuse of opiates, such as establishing opioid dispensing limits at
			 hospital emergency departments.</text>
			</paragraph>
    </section>
    <section id="HB6328140FE7F4776AF7BEC25372C4C15">
      <enum>7.</enum>
      <header>GAO report</header>
      <text display-inline="no-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="0500" entity-type="federal-body">Comptroller General of the United States</cato:entity-ref> shall—</text>
			<paragraph id="H54FDCA5852AB46FEB723E18204C66039">
        <enum>(1)</enum>
        <text>review opioid abuse programs, heroin abuse programs, and policies in Federal agencies and best
			 practices with respect to opioid and heroin abuse and overdose programs of
			 the States; and</text>
			</paragraph>
      <paragraph id="H162FA33E4B2A463C93600E7ECCDEFAA3">
        <enum>(2)</enum>
        <text>not later than 18 months after the date of enactment of this Act, issue a report to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> on its
			 findings and recommendations on ways to reduce opioid and heroin abuse and
			 overdoses.</text>
			</paragraph>
    </section>
  </legis-body>
</bill>
</doc>